KyungdongPharm Logo

KyungdongPharm

Develops and manufactures prescription drugs, OTC products, and pharmaceutical ingredients.

011040 | KO

Overview

Corporate Details

ISIN(s):
KR7011040003
LEI:
Country:
South Korea
Address:
경기도 화성시 양감면 제약단지로 224-3, 화성시

Description

KyungdongPharm is a pharmaceutical company engaged in the development, manufacturing, and distribution of medicines. Since its establishment in 1975, the company has focused on producing a broad portfolio of specialized therapeutic drugs and general pharmaceuticals. Its product lines encompass prescription medicines, with a focus on areas such as liver therapy, and over-the-counter products, including its prominent painkiller brand, 'Geunal-N'. The company also manufactures and supplies active pharmaceutical ingredients (APIs) and intermediates. Utilizing advanced production facilities and proprietary technology, KyungdongPharm is dedicated to developing high-quality medicines supported by clinical research to contribute to public health.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-03-30 00:00
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 8.4 KB
2023-03-30 00:00
정기주주총회결과
Korean 28.4 KB
2023-03-22 00:00
감사보고서제출
Korean 24.7 KB
2023-03-22 00:00
사업보고서 (2022.12)
Korean 1.8 MB
2023-03-15 00:00
주주총회소집공고
Korean 384.2 KB
2023-03-07 00:00
주주총회집중일개최사유신고
Korean 5.0 KB
2023-02-21 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 23.6 KB
2023-02-15 00:00
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean 10.7 KB
2023-02-15 00:00
현금ㆍ현물배당결정
Korean 8.6 KB
2023-02-15 00:00
주주총회소집결의
Korean 15.9 KB
2023-01-06 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.3 KB
2022-12-29 00:00
[기재정정]유형자산취득결정(자율공시)
Korean 13.4 KB
2022-12-15 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.1 KB
2022-11-14 00:00
분기보고서 (2022.09)
Korean 1.3 MB
2022-10-27 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.3 KB

Automate Your Workflow. Get a real-time feed of all KyungdongPharm filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for KyungdongPharm

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for KyungdongPharm via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.